money sack one hundred dollar bills

Follow the Funding, September 2017

This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.

TargetInvestorsAmountDate
Entasis TherapeuticsClarus Funds, Frazier Healthcare Partners, Novo A/S, Eventide Funds, Pivotal bioVenture, Sofinnova Ventures and TPG Biotech$31.9 million Series B-1September 5, 2017
Synergy PharmaceuticalsCRG LP$300 million debt fundingSeptember 5, 2017
Mid-Atlantic Dental PartnersS.C. Goldman and Company, LLC$12.5 million September 6, 2017
WuXi NextCODESequoia Capital and Temasek, Yunfeng Capital and 3W Partners$240 million Series BSeptember 7, 2017
TalkspaceQumra Capital and Norwest Venture Partners, Spark Capital, SoftBank, Compound Ventures and FirstTime.$31 million Series CSeptember 7, 2017
Cheetah MedicalMVM Life Science Partners, Springfield Investment Management, Fletcher Spaght Ventures, HighCape Partners and Robert Bosch Venture Capital$11.76 million Series CSeptember 12, 2017
Prellis BiologicsTrue Ventures$1.8 million seed roundSeptember 13, 2107
Carrot FertilitySoftTech VC with Maven Ventures, Percursor Ventures, Sound Ventures, Sherpa Ventures, Core VC, Founders Fund, Y Combinator and angel investors$3.6 million seed roundSeptember 14, 2017
Sonendo Inc. General Atlantic with Fjord Ventures, OrbiMed Advisors, Meritech Capital Partners, CVF LLC and NeoMed$50 millionSeptember 18, 2017
98point6Unidentified $19.5 million Series BSeptember 19, 2017
Landos BiopharmaPerceptive Advisors$10 million Series ASeptember 21, 2017
Fusion PharmaceuticalsAdams Street Partners with seroba Life Sciences and Varian Medical Systems Inc. $21 million Series A extensionSeptember 25, 2017
SpringWorks TherapeuticsBain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer and LifeArc$103 million Series ASeptember 25, 2017
Engage TherapeuticsTPG Biotech withAdage Capital Management and Lumira Capital $23 million Series ASeptember 27, 2017

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *